REZZAYO

Peak

rezafungin acetate

NDAINTRAVENOUSPOWDERPriority Review
Approved
Mar 2023
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

Pharmacologic Class:

Echinocandin Antifungal

Loss of Exclusivity

LOE Date
Jul 14, 2038
150 months away
Patent Expiry
Jul 14, 2038
Exclusivity Expiry
Mar 22, 2035

Patent Records (5)

Patent #ExpiryTypeUse Code
8722619
Mar 2, 2032
SubstanceProduct
U-3566
11654196
Mar 2, 2032
SubstanceProduct
U-3566
9526835
Mar 14, 2033
SubstanceProduct
U-3566
10702573
Mar 14, 2033
SubstanceProduct
U-3566
11712459
Mar 15, 2037
Product
U-3566
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers